StockDriftsStockDriftsTop 6 Bios Capital Management LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ACTU | ACTUATE THERAPEUTICS INC | 36.9% | 10.05M | $15.4M | +0.00%(+0) | $7.69(-87.32%) | 2026-06-30 | |
| IRD | OPUS GENETICS INC | 36.33% | 3.68M | $15.1M | +0.00%(+0) | $1.05(+254.52%) | 2026-06-30 | |
| CGTX | COGNITION THERAPEUTICS INC | 16.56% | 6.00M | $6.9M | +0.00%(+0) | $0.58(+76.92%) | 2026-06-30 | |
| RNTX | REIN THERAPEUTICS INC | 7.44% | 2.98M | $3.1M | +50.44%(+1.00M) | $2.16(-63.59%) | 2026-06-30 | |
| LTRN | LANTERN PHARMA INC | 2.5% | 249.4K | $1.0M | -71.15%(-615.04K) | $3.43(-20.55%) | 2026-06-30 | |
| INAB | IN8BIO INC | 0.27% | 81.0K | $114K | -51.76%(-86.85K) | $7.91(-85.07%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | -55.65% |
| Top 20 Holdings Unweighted | — | — | — | — | +27.29% |
Bios Capital Management LP reports $41.67M in US-listed equity holdings across 6 positions in its most recent 13F filing. Its largest disclosed positions are ACTU (36.9%), IRD (36.3%) and CGTX (16.6%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -55.65% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Bios Capital Management LP, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Bios Capital Management LP’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1813845). View Bios Capital Management LP’s 13F filings on SEC